$SAML
Samsara Luggage, Inc. Stock $saml

$saml Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024029049 Filed on April 02, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$1.099M	$3.000K	$361.0K
YoY Change	343.15%	-99.62%	-69.17%
Cost Of Revenue	$779.0K	$5.000K	$208.0K
YoY Change	433.56%	-99.07%	-74.7%
Gross Profit	$320.0K	-$2.000K	$153.0K
YoY Change	213.73%	-100.78%	-56.16%
Gross Profit Margin	29.12%	-66.67%	42.38%
Selling, General & Admin	$1.234M	$154.0K	$652.0K
YoY Change	570.65%	-53.89%	-26.99%
% of Gross Profit	385.63%		426.14%
Research & Development	$0.00	-$43.00K
YoY Change	-100.0%	-165.15%
% of Gross Profit	0.0%
Depreciation & Amortization	$69.00K
YoY Change
% of Gross Profit	21.56%
Operating Expenses	$1.234M	$111.0K	$652.0K
YoY Change	455.86%	-72.25%	-62.14%
Operating Profit	-$914.0K	-$113.0K	-$499.0K
YoY Change	661.67%	-20.42%	-63.66%
Interest Expense	$4.000K	$924.0K	$434.0K
YoY Change	-96.46%	-263.83%	1215.15%
% of Operating Profit
Other Income/Expense, Net	-$10.00K	-$79.00K	-$79.00K
YoY Change	-91.53%		-92.35%
Pretax Income	-$993.0K	$732.0K	-$144.0K
YoY Change	317.23%	-203.68%	-94.01%
Income Tax
% Of Pretax Income
Net Earnings	-$1.000M	$732.0K	-$144.0K
YoY Change	320.17%	-203.68%	-94.01%
Net Earnings / Revenue	-90.99%	24400.0%	-39.89%
Basic Earnings Per Share	-$0.01		$0.00
Diluted Earnings Per Share	$0.00	$0.05	-$0.02
COMMON SHARES
Basic Shares Outstanding	213.7M shares	11.62M shares	9.044M shares
Diluted Shares Outstanding			9.044M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$157.0K	$12.00K	$12.00K
YoY Change	175.44%	-92.86%	-92.86%
Cash & Equivalents	$157.0K	$12.00K	$12.00K
Short-Term Investments
Other Short-Term Assets	$160.0K	$0.00
YoY Change	7900.0%	-100.0%
Inventory	$892.0K	$0.00
Prepaid Expenses
Receivables	$1.134M
Other Receivables	$799.0K
Total Short-Term Assets	$3.275M	$12.00K	$12.00K
YoY Change	1430.37%	-96.52%	-96.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$78.00K	$0.00	$0.00
YoY Change
Goodwill	$327.0K	$0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments	$8.400M
YoY Change
Other Assets	$1.000K
YoY Change
Total Long-Term Assets	$9.454M	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$3.275M	$12.00K	$12.00K
Total Long-Term Assets	$9.454M	$0.00	$0.00
Total Assets	$12.73M	$12.00K	$12.00K
YoY Change	5848.13%	-96.52%	-96.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.966M	$327.0K	$327.0K
YoY Change	4472.09%	595.74%	595.74%
Accrued Expenses	$1.548M	$146.0K	$146.0K
YoY Change	338.53%	-48.77%	-48.77%
Deferred Revenue
YoY Change
Short-Term Debt	$1.304M	$1.398M	$1.398M
YoY Change	2.68%	13.84%	13.84%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.407M	$2.064M	$2.064M
YoY Change	122.88%	-11.03%	-11.03%
LONG-TERM LIABILITIES
Long-Term Debt	$710.0K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$153.0K	$0.00
YoY Change	37217.07%
Total Long-Term Liabilities	$863.0K	$0.00	$0.00
YoY Change	210387.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.407M	$2.064M	$2.064M
Total Long-Term Liabilities	$863.0K	$0.00	$0.00
Total Liabilities	$6.270M	$2.064M	$2.064M
YoY Change	158.45%	-11.03%	-11.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.74M	-$12.74M
YoY Change	7.06%	1.14%
Common Stock	$20.00K	$1.000K
YoY Change	1900.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.283M	-$2.052M	-$2.052M
YoY Change
Total Liabilities & Shareholders Equity	$12.73M	$12.00K	$12.00K
YoY Change	5848.13%	-96.52%	-96.52%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.000M	$732.0K	-$144.0K
YoY Change	320.17%	-203.68%	-94.01%
Depreciation, Depletion And Amortization	$69.00K
YoY Change
Cash From Operating Activities	$165.0K	-$110.0K	-$227.0K
YoY Change	-273.68%	547.06%	-74.89%
INVESTING ACTIVITIES
Capital Expenditures	$795.0K
YoY Change
Acquisitions	$8.400M
YoY Change
Other Investing Activities	-$8.401M
YoY Change
Cash From Investing Activities	-$9.523M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$66.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$9.503M	87.00K	71.00K
YoY Change	-59493.75%	45.0%	-71.02%
NET CHANGE
Cash From Operating Activities	$165.0K	-110.0K	-227.0K
Cash From Investing Activities	-$9.523M
Cash From Financing Activities	$9.503M	87.00K	71.00K
Net Change In Cash	$145.0K	-23.00K	-156.0K
YoY Change	-230.63%	-153.49%	-76.33%
FREE CASH FLOW
Cash From Operating Activities	$165.0K	-$110.0K	-$227.0K
Capital Expenditures	$795.0K
Free Cash Flow	-$630.0K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-54649
CY2023	dei	Entity Registrant Name EntityRegistrantName	SAMSARA LUGGAGE, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-0299456
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	6 Broadway
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 934
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10004
CY2023	dei	City Area Code CityAreaCode	917
CY2023	dei	Local Phone Number LocalPhoneNumber	522-3202
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	166110	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	213730601	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	Pipara & Co LLP
CY2023	dei	Auditor Firm AuditorFirmId	6841
CY2023	dei	Auditor Location AuditorLocation	Ahmedabad, India
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	168000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	155000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	21000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	12000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	345000	usd
CY2023Q4	us-gaap	Assets Assets	12000	usd
CY2022Q4	us-gaap	Assets Assets	345000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	327000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	47000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	146000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	285000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6000	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1398000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1167000	usd
CY2022Q4	saml	Fair Value Of Convertible Component In Convertible Loan Net Of Discounts And Debt Issue Costs FairValueOfConvertibleComponentInConvertibleLoanNetOfDiscountsAndDebtIssueCosts	632000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	61000	usd
CY2022Q4	saml	Fair Value Of Warrants Issued In Convertible Loan FairValueOfWarrantsIssuedInConvertibleLoan	1000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2064000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2320000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2064000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2320000	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	66000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	161000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	7500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	7500000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13922414	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13922414	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4406312	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4406312	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10625000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10464000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12744000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12600000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2118000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2136000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	345000	usd
CY2023	us-gaap	Revenues Revenues	361000	usd
CY2022	us-gaap	Revenues Revenues	1171000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	208000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	822000	usd
CY2023	us-gaap	Gross Profit GrossProfit	153000	usd
CY2022	us-gaap	Gross Profit GrossProfit	349000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	178000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	213000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	651000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	439000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	893000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	652000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1722000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-499000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1373000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	227000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	1243000	usd
CY2022	saml	Incomeexpenses In Respect Of Warrants Issued And Convertible Component In Convertible Loan IncomeexpensesInRespectOfWarrantsIssuedAndConvertibleComponentInConvertibleLoan	210000	usd
CY2023	saml	Write Off Assets WriteOffAssets	-79000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-306000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1033000	usd
CY2023	saml	Reversal Of Derivative Liability ReversalOfDerivativeLiability	661000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-144000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2406000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.84
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9043866	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2858961	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-698000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	395000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	193000	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	24000	usd
CY2022	saml	Amortization Of Services AmortizationOfServices	356000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2406000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2136000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	21000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	46000	usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	96000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-144000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2118000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-144000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2406000	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	152000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	356000	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	227000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1090000	usd
CY2023	saml	Expenses In Respect Of Warrants Issued And Convertible Component In Convertible Loan Net Interest Expenses ExpensesInRespectOfWarrantsIssuedAndConvertibleComponentInConvertibleLoanNetInterestExpenses	-694000	usd
CY2022	saml	Expenses In Respect Of Warrants Issued And Convertible Component In Convertible Loan Net Interest Expenses ExpensesInRespectOfWarrantsIssuedAndConvertibleComponentInConvertibleLoanNetInterestExpenses	-210000	usd
CY2022	us-gaap	Depreciation Depreciation	3000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-177000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	30000	usd
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	207000	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	141000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-227000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-904000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	185000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	66000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	60000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	71000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	245000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-156000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-659000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	827000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168000	usd
CY2023	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2300000	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	395000	usd
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	5549000	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	24000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	41000	usd
CY2024Q1	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	600685000	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	150753425	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.915	pure
CY2023	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	350000	shares
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">A critical accounting estimate is an estimate that: (i) is made in accordance with generally accepted accounting principles, (ii) involves a significant level of estimation uncertainty and (iii) has had or is reasonably likely to have a material impact on the Company’s financial condition or results of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">The Company’s Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP). The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts and related disclosures. On an ongoing basis, management evaluates and updates its estimates. Management employs judgment in making its estimates but they are based on historical experience and currently available information and various other assumptions that the Company believes to be reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily available from other sources. Actual results could differ from those estimates. Management believes that its judgment is applied consistently and produces financial information that fairly depicts the results of operations for all periods presented.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">Significant estimates include estimates used to review the Company’s, impairments and estimations of long-lived assets, revenue recognition of Contract based revenue, allowances for uncollectible accounts, and the valuations of non-cash capital stock issuances. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt"> </p>
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-144000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2406000	usd
CY2023	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-144000	usd
CY2022	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-2406000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9043866	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2858961	shares
CY2023	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	13922414	shares
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	4406312	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.84
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.84
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	226552	shares
CY2023	saml	Fixed Conversion Price FixedConversionPrice	0.004
CY2019Q4	us-gaap	Convertible Debt ConvertibleDebt	300000	usd
CY2019Q4	us-gaap	Convertible Debt ConvertibleDebt	600000	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	100000	usd
CY2020Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	70000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.10	pure
CY2023Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.10	pure
CY2023	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.80	pure
CY2023Q4	saml	Warrants To Purchase Shares Of Common Stock WarrantsToPurchaseSharesOfCommonStock	2619	shares
CY2023	saml	Class Of Warrant Or Righst Warrants Or Rights Exercisable Term ClassOfWarrantOrRighstWarrantsOrRightsExercisableTerm	P5Y
CY2021Q2	us-gaap	Convertible Debt ConvertibleDebt	150000	usd
CY2021Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.10	pure
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023	saml	Maturity Term MaturityTerm	P1Y
CY2023	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.80	pure
CY2023	saml	Outstanding Common Stock Percentage OutstandingCommonStockPercentage	0.0999	pure
CY2023	saml	Percentage Of Outstanding Principal Amount PercentageOfOutstandingPrincipalAmount	0.05	pure
CY2022	us-gaap	Debt Securities Available For Sale Accrued Interest Writeoff DebtSecuritiesAvailableForSaleAccruedInterestWriteoff	21000	usd
CY2022	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	1930635	shares
CY2022Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	103963	shares
CY2022Q2	saml	Fair Market Value FairMarketValue	45000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	113109	shares
CY2022Q2	saml	Fair Market Value FairMarketValue	29000	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	129000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	125000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	117244	shares
CY2022Q2	saml	Fair Market Value FairMarketValue	36000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	123288	shares
CY2022Q2	saml	Fair Market Value FairMarketValue	31000	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	130250	shares
CY2022Q3	saml	Fair Market Value FairMarketValue	38000	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	259404	shares
CY2022Q3	saml	Fair Market Value FairMarketValue	44000	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	295579	shares
CY2022Q3	saml	Fair Market Value FairMarketValue	35000	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	73312	shares
CY2022Q3	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	63000	usd
CY2022Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	60000	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	329252	shares
CY2022Q4	saml	Fair Market Value FairMarketValue	43000	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	363498	shares
CY2022Q4	saml	Fair Market Value FairMarketValue	39000	usd
CY2022Q4	saml	Investor Exercised InvestorExercised	13500	shares
CY2022Q4	saml	Shares Of Common Stock sharesOfCommonStock	209035	shares
CY2023Q1	saml	Investor Exercised InvestorExercised	10000	shares
CY2023Q1	saml	Shares Of Common Stock sharesOfCommonStock	219710	shares
CY2023Q1	saml	Investor Exercised InvestorExercised	9300	shares
CY2023Q1	saml	Shares Of Common Stock sharesOfCommonStock	229163	shares
CY2023Q1	saml	Investor Exercised InvestorExercised	9000	shares
CY2023Q1	saml	Shares Of Common Stock sharesOfCommonStock	240155	shares
CY2023Q1	saml	Investor Exercised InvestorExercised	6262	shares
CY2023Q1	saml	Shares Of Common Stock sharesOfCommonStock	250000	shares
CY2023Q1	saml	Investor Exercised InvestorExercised	6650	shares
CY2023Q1	saml	Shares Of Common Stock sharesOfCommonStock	265504	shares
CY2023Q1	saml	Investor Exercised InvestorExercised	7000	shares
CY2023Q1	saml	Shares Of Common Stock sharesOfCommonStock	277308	shares
CY2023Q2	saml	Investor Exercised InvestorExercised	7020	shares
CY2023Q2	saml	Shares Of Common Stock sharesOfCommonStock	290402	shares
CY2023Q2	saml	Investor Exercised InvestorExercised	6350	shares
CY2023Q2	saml	Shares Of Common Stock sharesOfCommonStock	305654	shares
CY2023Q2	saml	Investor Exercised InvestorExercised	6400	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	307828	shares
CY2023Q2	saml	Fair Market Value FairMarketValue	23417000	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	833333	shares
CY2023Q2	saml	Investor Exercised InvestorExercised	6400	shares
CY2023Q2	saml	Shares Of Common Stock sharesOfCommonStock	335842	shares
CY2023Q2	saml	Investor Exercised InvestorExercised	6950	shares
CY2023Q2	saml	Shares Of Common Stock sharesOfCommonStock	354183	shares
CY2023Q2	saml	Investor Exercised InvestorExercised	8850	shares
CY2023Q2	saml	Shares Of Common Stock sharesOfCommonStock	455388	shares
CY2023Q3	saml	Investor Exercised InvestorExercised	8000	shares
CY2023Q3	saml	Shares Of Common Stock sharesOfCommonStock	476405	shares
CY2023Q3	saml	Investor Exercised InvestorExercised	6250	shares
CY2023Q3	saml	Shares Of Common Stock sharesOfCommonStock	501894	shares
CY2023Q3	saml	Investor Exercised InvestorExercised	4464	shares
CY2023Q3	saml	Shares Of Common Stock sharesOfCommonStock	520000	shares
CY2023Q3	saml	Investor Exercised InvestorExercised	4464	shares
CY2023Q3	saml	Shares Of Common Stock sharesOfCommonStock	520000	shares
CY2023Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1150000	shares
CY2023Q4	saml	Fair Market Value FairMarketValue	11615000	usd
CY2023Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1150000	shares
CY2023Q4	saml	Fair Market Value FairMarketValue	11615000	usd
CY2023Q4	saml	Outstanding Shares Beginning Balance OutstandingSharesBeginningBalance	4406312	shares
CY2022Q4	saml	Outstanding Shares Beginning Balance OutstandingSharesBeginningBalance	2055487	shares
CY2023Q4	saml	Shares Issued Due To Conversion Of Notes SharesIssuedDueToConversionOfNotes	2300000	shares
CY2022Q4	saml	Shares Issued Due To Conversion Of Notes SharesIssuedDueToConversionOfNotes	1933045	shares
CY2023Q4	saml	Stock Based Compensation Management StockBasedCompensationManagement	1666666	shares
CY2022Q4	saml	Stock Based Compensation Service Provider StockBasedCompensationServiceProvider	27303	shares
CY2023Q4	saml	Conversion Of Preferred A Shares Into Common Shares ConversionOfPreferredASharesIntoCommonShares	5549436	shares
CY2022Q4	saml	Conversion Of Preferred A Shares Into Common Shares ConversionOfPreferredASharesIntoCommonShares	390477	shares
CY2023Q4	saml	Outstanding Shares Ending Balance OutstandingSharesEndingBalance	13922414	shares
CY2022Q4	saml	Outstanding Shares Ending Balance OutstandingSharesEndingBalance	4406312	shares
CY2023	saml	Percentage Of Common Stock Issued And Outstanding PercentageOfCommonStockIssuedAndOutstanding	0.0499	pure
CY2023Q4	saml	Conversion Price Percentage ConversionPricePercentage	0.80	pure
CY2023Q4	saml	Redemption Percentage RedemptionPercentage	1.20	pure
CY2023	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.15	pure
CY2023	us-gaap	Professional Fees ProfessionalFees	188000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	172000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	46000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	508000	usd
CY2023	us-gaap	Payment For Management Fee PaymentForManagementFee	100000	usd
CY2022	us-gaap	Payment For Management Fee PaymentForManagementFee	100000	usd
CY2023	us-gaap	Other Expenses OtherExpenses	105000	usd
CY2022	us-gaap	Other Expenses OtherExpenses	113000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	439000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	893000	usd
CY2024Q1	us-gaap	Shares Issued SharesIssued	1714286	shares
CY2023Q4	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	30000000	usd
CY2024Q1	us-gaap	Shares Issued SharesIssued	1666667	shares
CY2023Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	41667000	usd
CY2024Q1	us-gaap	Shares Issued SharesIssued	1714286	shares
CY2023Q4	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	281750000	usd
CY2024Q1	us-gaap	Shares Issued SharesIssued	2500	shares
CY2024Q1	us-gaap	Shares Issued SharesIssued	1666667	shares
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.84
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2858961	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9043866	shares
CY2023	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization		usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
CY2022Q4	saml	Stock Based Compensation Management StockBasedCompensationManagement		shares
CY2023Q4	saml	Stock Based Compensation Service Provider StockBasedCompensationServiceProvider		shares
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001530163

Files In Submission

Name	View Source	Status
0001213900-24-029049-index-headers.html	Edgar Link	pending
0001213900-24-029049-index.html	Edgar Link	pending
0001213900-24-029049.txt	Edgar Link	pending
0001213900-24-029049-xbrl.zip	Edgar Link	pending
ea0202327-10k_samsara.htm	Edgar Link	pending
ea020232701ex10-18_samsara.htm	Edgar Link	pending
ea020232701ex10-19_samsara.htm	Edgar Link	pending
ea020232701ex10-20_samsara.htm	Edgar Link	pending
ea020232701ex10-21_samsara.htm	Edgar Link	pending
ea020232701ex10-22_samsara.htm	Edgar Link	pending
ea020232701ex10-23_samsara.htm	Edgar Link	pending
ea020232701ex10-24_samsara.htm	Edgar Link	pending
ea020232701ex10-25_samsara.htm	Edgar Link	pending
ea020232701ex10-26_samsara.htm	Edgar Link	pending
ea020232701ex10-27_samsara.htm	Edgar Link	pending
ea020232701ex10-28_samsara.htm	Edgar Link	pending
ea020232701ex10-30_samsara.htm	Edgar Link	pending
ea020232701ex14-1_samsara.htm	Edgar Link	pending
ea020232701ex14-2_samsara.htm	Edgar Link	pending
ea020232701ex3-9_samsara.htm	Edgar Link	pending
ea020232701ex31-1_samsara.htm	Edgar Link	pending
ea020232701ex32-1_samsara.htm	Edgar Link	pending
ex10-18_001.jpg	Edgar Link	pending
ex10-18_002.jpg	Edgar Link	pending
ex10-18_003.jpg	Edgar Link	pending
ex10-18_004.jpg	Edgar Link	pending
ex10-18_005.jpg	Edgar Link	pending
ex10-18_006.jpg	Edgar Link	pending
ex10-18_007.jpg	Edgar Link	pending
ex10-18_008.jpg	Edgar Link	pending
ex10-18_009.jpg	Edgar Link	pending
ex10-18_010.jpg	Edgar Link	pending
ex10-18_011.jpg	Edgar Link	pending
ex10-18_012.jpg	Edgar Link	pending
ex10-18_013.jpg	Edgar Link	pending
ex10-18_014.jpg	Edgar Link	pending
ex10-18_015.jpg	Edgar Link	pending
ex10-18_016.jpg	Edgar Link	pending
ex10-18_017.jpg	Edgar Link	pending
ex10-18_018.jpg	Edgar Link	pending
ex10-18_019.jpg	Edgar Link	pending
ex10-19_001.jpg	Edgar Link	pending
ex10-19_002.jpg	Edgar Link	pending
ex10-19_003.jpg	Edgar Link	pending
ex10-19_004.jpg	Edgar Link	pending
ex10-19_005.jpg	Edgar Link	pending
ex10-19_006.jpg	Edgar Link	pending
ex10-19_007.jpg	Edgar Link	pending
ex10-19_008.jpg	Edgar Link	pending
ex10-19_009.jpg	Edgar Link	pending
ex10-19_010.jpg	Edgar Link	pending
ex10-19_011.jpg	Edgar Link	pending
ex10-19_012.jpg	Edgar Link	pending
ex10-19_013.jpg	Edgar Link	pending
ex10-19_014.jpg	Edgar Link	pending
ex10-19_015.jpg	Edgar Link	pending
ex10-19_016.jpg	Edgar Link	pending
ex10-19_017.jpg	Edgar Link	pending
ex10-19_018.jpg	Edgar Link	pending
ex10-20_001.jpg	Edgar Link	pending
ex10-20_002.jpg	Edgar Link	pending
ex10-20_003.jpg	Edgar Link	pending
ex10-20_004.jpg	Edgar Link	pending
ex10-20_005.jpg	Edgar Link	pending
ex10-20_006.jpg	Edgar Link	pending
ex10-20_007.jpg	Edgar Link	pending
ex10-20_008.jpg	Edgar Link	pending
ex10-20_009.jpg	Edgar Link	pending
ex10-20_010.jpg	Edgar Link	pending
ex10-20_011.jpg	Edgar Link	pending
ex10-20_012.jpg	Edgar Link	pending
ex10-20_013.jpg	Edgar Link	pending
ex10-20_014.jpg	Edgar Link	pending
ex10-20_015.jpg	Edgar Link	pending
ex10-20_016.jpg	Edgar Link	pending
ex10-20_017.jpg	Edgar Link	pending
ex10-20_018.jpg	Edgar Link	pending
ex10-20_019.jpg	Edgar Link	pending
ex14-1_001.jpg	Edgar Link	pending
ex14-1_002.jpg	Edgar Link	pending
ex14-2_001.jpg	Edgar Link	pending
ex14-2_002.jpg	Edgar Link	pending
ex3-9_001.jpg	Edgar Link	pending
ex3-9_002.jpg	Edgar Link	pending
ex3-9_003.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
fin_003.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
image_015.jpg	Edgar Link	pending
image_016.jpg	Edgar Link	pending
image_017.jpg	Edgar Link	pending
image_018.jpg	Edgar Link	pending
image_019.jpg	Edgar Link	pending
image_020.jpg	Edgar Link	pending
image_021.jpg	Edgar Link	pending
image_022.jpg	Edgar Link	pending
image_023.jpg	Edgar Link	pending
image_024.jpg	Edgar Link	pending
image_025.jpg	Edgar Link	pending
image_026.jpg	Edgar Link	pending
image_027.jpg	Edgar Link	pending
image_028.jpg	Edgar Link	pending
image_029.jpg	Edgar Link	pending
image_030.jpg	Edgar Link	pending
image_031.jpg	Edgar Link	pending
image_032.jpg	Edgar Link	pending
image_033.jpg	Edgar Link	pending
image_034.jpg	Edgar Link	pending
image_035.jpg	Edgar Link	pending
image_036.jpg	Edgar Link	pending
image_037.jpg	Edgar Link	pending
image_038.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
saml-20231231.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
saml-20231231_def.xml	Edgar Link	unprocessable
saml-20231231_lab.xml	Edgar Link	unprocessable
saml-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
saml-20231231_cal.xml	Edgar Link	unprocessable
ea0202327-10k_samsara_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SAML
Samsara Luggage, Inc. Stock $saml

2024 Q1 Form 10-K Financial Statement

#000121390024029049 Filed on April 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SAML Samsara Luggage, Inc. Stock $saml

2024 Q1 Form 10-K Financial Statement

#000121390024029049 Filed on April 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SAML
Samsara Luggage, Inc. Stock $saml